Key result
Cardiac CT finds significant CAD in 44% of radiotherapy-eligible esophageal cancer patients without known IHD.
Why the study?
Radiation therapy for esophageal cancer involves elevated cardiac radiation exposure, and shared risk factors exist, but the prevalence of coronary artery disease in RT-eligible patients was unclear.
Does pre-radiotherapy cardiac CT identify a high prevalence of coronary artery disease in patients with esophageal cancer without a history of ischemic heart disease?
Observational (n=41)
No
Does pre-radiotherapy cardiac CT identify a high prevalence of coronary artery disease in patients with esophageal cancer without a history of ischemic heart disease?
Pre-treatment cardiac CT reveals a high prevalence of undiagnosed coronary artery disease in patients with esophageal cancer eligible for radiotherapy, highlighting the importance of baseline cardiac evaluation in this population.
May warrant baseline cardiac CT before radiotherapy; leaves open whether screening improves outcomes.
BACKGROUND: Assessment of cardiac disease before cancer therapy is crucial, as advancements in cancer treatment have led to prolonged survival and an increase in cardiovascular complications. Specifically, esophageal cancer and heart disease share common risk factors, such as smoking and obesity. Radiation therapy (RT) for esophageal cancer is associated with elevated cardiac radiation exposure. This study aimed to assess the prevalence of coronary artery disease (CAD) in patients with esophageal cancer who were eligible for RT. METHODS: We examined the prevalence of coronary artery stenosis, abnormal myocardial perfusion, and late enhancement using pre-RT cardiac computed tomography (CT) data of 41 patients with thoracic esophageal cancer who were referred for RT between January 2017 and June 2023 and had no history of ischemic heart disease. RESULTS: The median age of the 41 patients was 71 years, with 40 patients being male. Cardiac CT identified significant coronary stenosis (≥50% luminal narrowing) in 18 patients (44%), among whom 9 (50%) had severe stenosis, multivessel disease, or myocardial ischemia. Significant stenosis was most frequently observed in the left anterior descending artery (16/18). Late enhancement, indicating myocardial infarction, was observed in seven patients (17%). INTERPRETATION: Patients with esophageal cancer without a history of ischemic heart disease had a high prevalence (44%) of CAD, with half of them having severe stenosis, multivessel disease, or myocardial ischemia. Given the high prevalence of coronary stenosis, pre-treatment cardiac evaluation is crucial for patients with esophageal cancer. Incorporating cardiac CT findings into radiotherapy planning is recommended to optimize patient care.
No takes yet. Share an insight, caveat, or question.
Takada et al. (2025) conducted an observational in Esophageal cancer eligible for radiotherapy (n=41). Comprehensive cardiac CT was evaluated on Prevalence of significant coronary stenosis (≥50% luminal narrowing). Comprehensive cardiac CT revealed a 44% prevalence of significant coronary artery disease in patients with esophageal cancer eligible for radiotherapy who had no history of ischemic heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: